$BNGO I think the ASHG conference October 27th will update a lot on enhancements to the Saphyr. The COO was bullish last year at the ASHG on improvements and I'm hoping he presents further developments. Its important we continue to cut the cost for a sample to be run on Bionano as the race to $100 sequencing samples is hot between BGI and Illumina. Its very important we compete at that price level. We must employ sample multiplexing and increasing flow cells per chip to cut sample costs. As our demand increases with adoptions we should be able to leverage better manufacturing purchase contracts to lower costs and increase margins.